05196nam 2200637 a 450 991045169500332120210511193449.01-281-76379-997866117637940-08-055053-3(CKB)1000000000489280(EBL)403775(OCoLC)476215780(SSID)ssj0000116619(PQKBManifestationID)11131917(PQKBTitleCode)TC0000116619(PQKBWorkID)10036207(PQKB)11389442(MiAaPQ)EBC403775(Au-PeEL)EBL403775(CaPaEBR)ebr10371831(CaONFJC)MIL176379(EXLCZ)99100000000048928020070619d2007 uy 0engur|n|---|||||txtccrAnnotated C# standard[electronic resource] /Jon Jagger, Nigel Perry, Peter SestoftAmsterdam ;Boston Elsevier/Morgan Kaufmann Publishersc20071 online resource (858 p.)Description based upon print version of record.0-12-372511-9 Includes bibliographical references (p. 804) and index.Front Cover; C# Annotated Standard; Copyright Page; Dedications; Contents; Foreword to the Annotated Standard; Preface to the Annotated Standard; Acknowledgments; About The Authors; Errata To The International Standard; The C# International Standard and Foreword; Introduction; CLI not required; Chapter 1: Scope; Chapter 2: Conformance; Interpreters; Chapter 3: Normative references; Chapter 4: Definitions; Application vs. program; Assembly vs. class files; Accessing class libraries; Programs, assemblies, applications and class libraries; Chapter 5: Notational conventionsChapter 6: Acronyms and abbreviationsASCII Rules!; The C# name; Chapter 7: General description; Where to look for requirements on unsafe constructs; Chapter 8: Language overview; Annotation free zone; 8.1 Getting started; 8.2 Types; 8.2.1 Predefined types; 8.2.2 Conversions; 8.2.3 Array types; 8.2.4 Type system unification; 8.3 Variables and parameters; 8.4 Automatic memory management; 8.5 Expressions; 8.6 Statements; 8.7 Classes; 8.7.1 Constants; 8.7.2 Fields; 8.7.3 Methods; 8.7.4 Properties; 8.7.5 Events; 8.7.6 Operators; 8.7.7 Indexers; 8.7.8 Instance constructors; 8.7.9 Finalizers8.7.10 Static constructors8.7.11 Inheritance; 8.7.12 Static classes; 8.7.13 Partial type declarations; 8.8 Structs; 8.9 Interfaces; 8.10 Delegates; 8.11 Enums; 8.12 Namespaces and assemblies; 8.13 Versioning; 8.14 Extern aliases; 8.15 Attributes; 8.16 Generics; 8.16.1 Why generics?; 8.16.2 Creating and consuming generics; 8.16.3 Multiple type parameters; 8.16.4 Constraints; 8.16.5 Generic methods; 8.17 Anonymous methods; 8.18 Iterators; 8.19 Nullable types; Chapter 9: Lexical structure; 9.1 Programs; Much ado about nothing; 9.2 Grammars; 9.2.1 Lexical grammar; 9.2.2 Syntactic grammar9.2.3 Grammar ambiguitiesRationale: the "following token" set; Similar cast expression ambiguity; F(G>7); 9.3 Lexical analysis; 9.3.1 Line terminators; 9.3.2 Comments; 9.3.3 White space; 9.4 Tokens; 9.4.1 Unicode escape sequences; No escapes in verbatim strings; No escapes in comments; 9.4.2 Identifiers; Identifier normalization; The humble underscore; Keyword escape mechanism; Code generation; 9.4.3 Keywords; Language evolution; 9.4.4 Literals; 9.4.4.1 Boolean literals; Boolean arguments considered harmful?; 9.4.4.2 Integer literals; Historical note; Boundary differences9.4.4.3 Real literalsWhat is 1.D?; Money or deciMal?; 9.4.4.4 Character literals; No octal character escapes; 9.4.4.5 String literals; Platform independent newlines; Historical note; Happy birthday, Joel; Overspecification...; Hexadecimal escape character pitfalls; 9.4.4.6 The null literal; 9.4.5 Operators and punctuators; >>== tokenization oddity; Tokenization anecdote; 9.5 Pre-processing directives; To pre-process, or not pre-process?; Why no delimited comments in #directives?; Why no macros?; 9.5.1 Conditional compilation symbols; Conditional symbol oddityNo program-wide pre-processing symbolsStandards, while being definitive, do not usually serve as the best reference to the use of a programming language. Books on languages usually are able to explain usage better, but lack the definitive precision of a standard. This book combines the two; it is the standard with added explanatory material.* Written by members of the standards committee* Annotates the standard with practical implementation advice* The definitive reference to the C# International StandardC (Computer program language)Electronic books.C (Computer program language)005.13/3Jagger Jon1966-64021Perry Nigel959934Sestoft Peter740270MiAaPQMiAaPQMiAaPQBOOK9910451695003321Annotated C# standard2175685UNINA05289nam 2201369z- 450 991055754520332120231214133613.0(CKB)5400000000044155(oapen)https://directory.doabooks.org/handle/20.500.12854/76606(EXLCZ)99540000000004415520202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierSphingolipidsFrom Pathology to Therapeutic Perspectives - A Themed Honorary Issue to Prof. Lina ObeidBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (292 p.)3-03943-957-X 3-03943-958-8 Although sphingolipids are ubiquitous components of cellular membranes, their abundance in cells is generally lower than glycerolipids or cholesterol, representing less than 20% of total lipid mass. Following their discovery in the brain—which contains the largest amounts of sphingolipids in the body—and first description in 1884 by J.L.W. Thudichum, sphingolipids have been overlooked for almost a century, perhaps due to their complexity and enigmatic nature. When sphingolipidoses were discovered, a series of inherited diseases caused by enzyme mutations involved in sphingolipid degradation returned to the limelight. The essential breakthrough came decades later, in the 1990s, with the discovery that sphingolipids were not just structural elements of cellular membranes but intra- and extracellular signaling molecules. It turned out that their lipid backbones, including ceramide and sphingosine-1-phosphate, had selective physiological functions. Thus, sphingolipids emerged as essential players in several pathologies including cancer, diabetes, neurodegenerative disorders, and autoimmune diseases. The present volume reflects upon the unexpectedly eclectic functions of sphingolipids in health, disease, and therapy. This fascinating lipid class will continue to be the subject of up-and-coming future discoveries, especially with regard to new therapeutic strategies.Sphingolipids Research & information: generalbicsscBiology, life sciencesbicsscS1P receptorinflammationS1P transporterspinster homolog 2barrier dysfunctionanxietydepressionsphingolipidssphingomyelinaseceramidaseSmpd1acid sphingomyelinaseforebraindepressive-like behavioranxiety-like behaviorceramideceramidesceramidasesneurodegenerative diseasesinfectious diseasessphingosine 1-phoshatesphingosine 1-phosphate receptorS1P1-5sphingosine 1-phosphate metabolismsphingosine 1-phosphate antagonistst/inhibitorssphingosine 1-phosphate signalingstrokemultiple sclerosisneurodegenerationfingolimodSphingosine-1-phosphateobesitytype 2 diabetesinsulin resistancepancreatic β cell fatehypothalamussphingosine-1-phosphateischemia/reperfusioncardioprotectionvasoconstrictioncoronary flowmyocardial functionmyocardial infarctalbumintype 1 diabetesbeta-cellsisletsinsulincytokinesS1Panimal modelscystic fibrosisautophagymyriocinAspergillus fumigatusCLN3 diseaseCln3Δex7/8 miceflupirtineallyl carbamate derivativeapoptosiscancergangliosidesimmunotherapymetastasisphenotype switchingsphingosine 1-phosphateSphingosine 1-phosphate (S1P)S1P-lyase (SGPL1)taucalciumhistone acetylationhippocampuscortexastrocytesneuronssphingosine kinaseG-protein-coupled receptorsGαq/11sphingosine kinase 1SK1microRNAtranscription factorhypoxialong non-coding RNAResearch & information: generalBiology, life sciencesvan Echten-Deckert Gerhildedt1307154van Echten-Deckert GerhildothBOOK9910557545203321Sphingolipids3028702UNINA